JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 37.00
-0.50 (-1.33%)
Jul 24, 2026, 4:08 PM HKT
JD Health International Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, JD Health International stock has a consensus rating of "Strong Buy" and an average price target of $71.14. The average 1-year stock price forecast is 92.27% higher than the current stock price, while the lowest is $61.22 (+65.46%) and the highest is $94.84 (+156.32%).
Price Target: $71.14 (+92.27%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for JD Health International stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 15 | 14 | 14 | 14 | 14 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Maintains $65.00 | Buy | Maintains | $65.00 | +75.68% | Jul 17, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $70.70 → $61.90 | Buy | Maintains | $70.70 → $61.90 | +67.30% | Jul 3, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $74.00 | Buy | Maintains | $74.00 | +100.00% | Jun 3, 2026 |
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Buy Maintains $75.00 → $68.00 | Buy | Maintains | $75.00 → $68.00 | +83.78% | May 22, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $66.20 | Buy | Maintains | $66.20 | +78.92% | May 17, 2026 |
Financial Forecast
Revenue This Year
86.62B
from 73.44B
Increased by 17.95%
Revenue Next Year
99.94B
from 86.62B
Increased by 15.38%
EPS This Year
2.08
from 2.04
Increased by 1.52%
EPS Next Year
2.44
from 2.08
Increased by 17.61%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.